双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002693 双成药业

已收盘 07-19 15:00:00

{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"双成药业","latestPrice":4.24,"timestamp":1721372586000,"preClose":4.23,"halted":0,"volume":2738700,"delay":0,"floatShares":411000000,"shares":417000000,"eps":-0.1536,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"07-19 15:00:00","open":4.21,"high":4.25,"low":4.16,"amount":11543700,"amplitude":0.0213,"askPrice":4.24,"askSize":830,"bidPrice":4.23,"bidSize":762,"shortable":0,"etf":0,"ttmEps":-0.1536,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":4.23,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":4.65,"lowLimit":3.81,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":416789750,"pbRate":3.81,"roa":"--","roe":"--","epsLYR":-0.12,"committee":-0.098092,"marketValue":1767000000,"floatMarketCap":1744000000,"peRate":-27.604165,"changeRate":0.0024,"turnoverRate":0.0067,"status":0},"requestUrl":"/m/hq/s/002693","defaultTab":"news","newsList":[{"id":"2450851872","title":"双成药业（002693）7月10日主力资金净卖出358.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450851872","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450851872?lang=zh_cn&edition=full","pubTime":"2024-07-10 15:24","pubTimestamp":1720596261,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月10日收盘，双成药业报收于4.13元，下跌4.4%，换手率1.38%，成交量5.68万手，成交额2372.1万元。7月10日的资金流向数据方面，主力资金净流出358.62万元，占总成交额15.12%，游资资金净流入58.46万元，占总成交额2.46%，散户资金净流入300.16万元，占总成交额12.65%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000026911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2450043146","title":"双成药业最新公告：预计上半年净利亏损1300万元–1900万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450043146","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450043146?lang=zh_cn&edition=full","pubTime":"2024-07-09 19:30","pubTimestamp":1720524630,"startTime":"0","endTime":"0","summary":"双成药业公告，预计上半年净利亏损1300万元–1900万元，上年同期盈利879.03万元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900042722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2448416838","title":"双成药业（002693）7月4日主力资金净卖出214.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448416838","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448416838?lang=zh_cn&edition=full","pubTime":"2024-07-04 15:32","pubTimestamp":1720078326,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月4日收盘，双成药业报收于4.28元，下跌4.89%，换手率1.27%，成交量5.2万手，成交额2257.16万元。7月4日的资金流向数据方面，主力资金净流出214.22万元，占总成交额9.49%，游资资金净流出22.35万元，占总成交额0.99%，散户资金净流入236.57万元，占总成交额10.48%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400025063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2445704031","title":"双成药业(002693.SZ)控股股东解押3200万股 占总股本7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445704031","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445704031?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:43","pubTimestamp":1719218598,"startTime":"0","endTime":"0","summary":"双成药业(002693.SZ)发布公告，公司于近日接到公司控股股东海南双成投资有限...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2444213534","title":"双成药业最新公告：宁波双成药品生产许可证变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2444213534","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444213534?lang=zh_cn&edition=full","pubTime":"2024-06-20 20:01","pubTimestamp":1718884894,"startTime":"0","endTime":"0","summary":"双成药业公告，公司的控股子公司宁波双成药业有限公司于近日取得浙江省药品监督管理局换发的《药品生产许可证》。本次涉及变更的事项为：同意宁波双成在委托或受托情况中新增受托企业名称为浙江和泽医药科技股份有限公司，生产/注册地址为浙江省杭州市钱塘区下沙街道1号大街101号4幢201室，药品名称为KY-XES，批准文号无，联合申报注册，委托有效期至2027年11月13日。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000038036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2443029508","title":"双成药业：公司的产品醋酸奥曲肽注射液美国市场目前还未上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2443029508","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443029508?lang=zh_cn&edition=full","pubTime":"2024-06-13 18:02","pubTimestamp":1718272928,"startTime":"0","endTime":"0","summary":"证券之星消息，双成药业06月13日在投资者关系平台上答复投资者关心的问题。公司的产品醋酸奥曲肽注射液美国市场目前还未上市销售。控股子公司宁波双成的产品 ANDA 美国FDA批文及所有权、国内有关的特定知识产权和生产技术均已转让。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061300034230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2437378814","title":"双成药业（002693）5月23日主力资金净卖出1204.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437378814","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437378814?lang=zh_cn&edition=full","pubTime":"2024-05-23 15:28","pubTimestamp":1716449287,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月23日收盘，双成药业报收于5.38元，下跌4.95%，换手率3.34%，成交量13.73万手，成交额7470.02万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：双成药业2024年一季报显示，公司主营收入4276.17万元，同比下降47.52%；归母净利润-874.27万元，同比下降294.04%；扣非净利润-905.27万元，同比下降665.86%；负债率36.92%，投资收益18.31万元，财务费用197.25万元，毛利率60.06%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052300023108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2437234279","title":"双成药业（002693）5月22日主力资金净买入460.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437234279","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437234279?lang=zh_cn&edition=full","pubTime":"2024-05-22 15:23","pubTimestamp":1716362608,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月22日收盘，双成药业报收于5.66元，上涨2.91%，换手率4.13%，成交量16.98万手，成交额9572.99万元。5月22日的资金流向数据方面，主力资金净流入460.48万元，占总成交额4.81%，游资资金净流入63.25万元，占总成交额0.66%，散户资金净流出523.73万元，占总成交额5.47%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052200022353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2437311499","title":"双成药业最新公告：控股子公司通过GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2437311499","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437311499?lang=zh_cn&edition=full","pubTime":"2024-05-21 16:51","pubTimestamp":1716281473,"startTime":"0","endTime":"0","summary":"双成药业公告，控股子公司宁波双成药业有限公司从浙江省药品监督管理局网站获悉宁波双成口服固体一车间，胶囊生产线通过GMP符合性检查。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052100027217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2437496569","title":"双成药业(002693.SZ)：宁波子公司通过GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2437496569","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437496569?lang=zh_cn&edition=full","pubTime":"2024-05-21 16:42","pubTimestamp":1716280969,"startTime":"0","endTime":"0","summary":"智通财经APP讯，双成药业(002693.SZ)公告，公司控股子公司宁波双成药业有限公司(“宁波双成”)获悉宁波双成口服固体一车间，胶囊生产线通过GMP符合性检查。据悉，本次检查范围为胶囊剂普瑞巴林胶囊，普瑞巴林是神经递质γ-氨基丁酸(GABA)的一种类似物，为加巴喷丁的后续产品。普瑞巴林胶囊已被国家药品监督管理局批准用于带状疱疹后神经痛和纤维肌痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1123851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2435680216","title":"双成药业：“公司是用化学的方法合成具有生物活性的多肽药物”，是化学合成","url":"https://stock-news.laohu8.com/highlight/detail?id=2435680216","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435680216?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:02","pubTimestamp":1715767362,"startTime":"0","endTime":"0","summary":"证券之星消息，双成药业(002693)05月15日在投资者关系平台上答复投资者关心的问题。投资者：7日公司回复“公司是用化学的方法合成具有生物活性的多肽药物。”，请问到底是化学合成还是生物合成？属不属于合成生物？谢谢双成药业董秘：尊敬的投资者您好，感谢您的关注。“公司是用化学的方法合成具有生物活性的多肽药物”，是化学合成。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500030900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2435990575","title":"双成药业：5月14日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2435990575","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435990575?lang=zh_cn&edition=full","pubTime":"2024-05-14 19:09","pubTimestamp":1715684982,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年5月14日双成药业发布公告称公司于2024年5月14日召开业绩说明会。建立积极的企业文化，促进员工的参与和忠诚度。加强股东沟通与投资者关系保持良好的股东沟通，及时应投资者关注和问题。双成药业2024年一季报显示，公司主营收入4276.17万元，同比下降47.52%；归母净利润-874.27万元，同比下降294.04%；扣非净利润-905.27万元，同比下降665.86%；负债率36.92%，投资收益18.31万元，财务费用197.25万元，毛利率60.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400028472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2435563051","title":"双成药业（002693）5月14日主力资金净卖出3358.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435563051","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435563051?lang=zh_cn&edition=full","pubTime":"2024-05-14 15:29","pubTimestamp":1715671746,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月14日收盘，双成药业报收于6.13元，下跌1.45%，换手率13.7%，成交量56.35万手，成交额3.59亿元。5月14日的资金流向数据方面，主力资金净流出3358.04万元，占总成交额9.34%，游资资金净流入722.93万元，占总成交额2.01%，散户资金净流入2635.11万元，占总成交额7.33%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400016113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2435348644","title":"5月13日双成药业涨停分析：海南概念，阿尔茨海默病，自贸区概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435348644","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435348644?lang=zh_cn&edition=full","pubTime":"2024-05-13 15:31","pubTimestamp":1715585462,"startTime":"0","endTime":"0","summary":"证券之星消息，双成药业涨停收盘，收盘价6.22元。该股于9点30分涨停，未打开涨停，截止收盘封单资金为3565.99万元，占其流通市值1.39%。5月13日的资金流向数据方面，主力资金净流入7267.29万元，占总成交额70.35%，游资资金净流出3024.31万元，占总成交额29.27%，散户资金净流出4242.98万元，占总成交额41.07%。近5日资金流向一览见下表：该股为海南概念，阿尔茨海默病，自贸区概念热股。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300008936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2435317260","title":"双成药业（002693）5月13日主力资金净买入7267.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435317260","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435317260?lang=zh_cn&edition=full","pubTime":"2024-05-13 15:19","pubTimestamp":1715584795,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月13日收盘，双成药业报收于6.22元，上涨10.09%，涨停，换手率4.07%，成交量16.75万手，成交额1.03亿元。5月13日的资金流向数据方面，主力资金净流入7267.29万元，占总成交额70.35%，游资资金净流出3024.31万元，占总成交额29.27%，散户资金净流出4242.98万元，占总成交额41.07%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300008375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2435139325","title":"异动快报：双成药业（002693）5月13日9点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2435139325","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435139325?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:36","pubTimestamp":1715564162,"startTime":"0","endTime":"0","summary":"证券之星5月13日盘中消息，9点30分双成药业触及涨停板。目前价格6.22，上涨10.09%。其所属行业化学制药目前下跌。领涨股为鲁抗医药。该股为阿尔茨海默病，肝炎概念，医药概念热股，当日阿尔茨海默病概念上涨0.18%，肝炎概念概念上涨0.01%。5月10日的资金流向数据方面，主力资金净流出628.35万元，占总成交额3.87%，游资资金净流入441.55万元，占总成交额2.72%，散户资金净流入186.81万元，占总成交额1.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300002691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2433371502","title":"5月8日双成药业涨停分析：阿尔茨海默病，肝炎概念，医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433371502","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433371502?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:35","pubTimestamp":1715153725,"startTime":"0","endTime":"0","summary":"证券之星消息，双成药业涨停收盘，收盘价5.93元。该股于9点32分涨停，未打开涨停，截止收盘封单资金为2822.74万元，占其流通市值1.16%。5月8日的资金流向数据方面，主力资金净流入3653.14万元，占总成交额43.6%，游资资金净流出1534.44万元，占总成交额18.31%，散户资金净流出2118.7万元，占总成交额25.28%。近5日资金流向一览见下表：该股为阿尔茨海默病，肝炎概念，医药概念热股，当日阿尔茨海默病概念上涨1.31%，肝炎概念概念上涨0.8%，医药概念上涨0.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800022379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK1161","09939","BK1574","159938","BK1515","BK0239"],"gpt_icon":0},{"id":"2433713663","title":"双成药业（002693）5月8日主力资金净买入3653.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433713663","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433713663?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:19","pubTimestamp":1715152742,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月8日收盘，双成药业报收于5.93元，上涨10.02%，涨停，换手率3.47%，成交量14.29万手，成交额8379.4万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：双成药业2024年一季报显示，公司主营收入4276.17万元，同比下降47.52%；归母净利润-874.27万元，同比下降294.04%；扣非净利润-905.27万元，同比下降665.86%；负债率36.92%，投资收益18.31万元，财务费用197.25万元，毛利率60.06%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800021164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2433669657","title":"异动快报：双成药业（002693）5月8日9点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2433669657","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433669657?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:35","pubTimestamp":1715132154,"startTime":"0","endTime":"0","summary":"证券之星5月8日盘中消息，9点32分双成药业触及涨停板。目前价格5.93，上涨10.02%。其所属行业化学制药目前上涨。领涨股为拓新药业。该股为医药，肝炎概念，阿尔茨海默病概念热股，当日医药概念上涨0.72%，肝炎概念概念上涨0.01%。5月7日的资金流向数据方面，主力资金净流入245.25万元，占总成交额3.22%，游资资金净流出620.69万元，占总成交额8.14%，散户资金净流入375.44万元，占总成交额4.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800014865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2433727437","title":"双成药业：公司是用化学的方法合成具有生物活性的多肽药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2433727437","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433727437?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:02","pubTimestamp":1715079720,"startTime":"0","endTime":"0","summary":"证券之星消息，双成药业(002693)05月07日在投资者关系平台上答复投资者关心的问题。投资者：贵司资料显示主营业务化学合成多肽药品的生产、销售和研发，与近期火爆的合成生物不谋而合，在这里还是问一下：贵司有合成生物技术吗？双成药业董秘：尊敬的投资者您好，感谢您的关注。公司是用化学的方法合成具有生物活性的多肽药物。谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700031927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","stockEarnings":[{"period":"1week","weight":-0.0162},{"period":"1month","weight":-0.0742},{"period":"3month","weight":-0.113},{"period":"6month","weight":-0.3624},{"period":"1year","weight":-0.2922},{"period":"ytd","weight":-0.4354}],"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","perCapita":"10356股","boardName":"医药制造业","registeredCapital":"41678万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":"　　海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。主要产品有基泰（品名）注射用胸腺法新、注射用比伐芦定、注射用左卡尼汀、注射用盐酸克林霉素、注射用法莫替丁、注射用生长抑素、注射用磷酸川芎嗪。公司现为国家高新技术企业，主导产品“基泰”药品质量和适应症与原研参比制剂一致，并已获得原研药注册地意大利药品管理局颁发的注射用胸腺法新（基泰）上市许可证，质量层次已达到和原研药同等的标准。","serverTime":1721492884242,"listedPrice":20,"stockholders":"39723人(较上一季度减少12.69%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"双成药业,002693,双成药业股票,双成药业股票老虎,双成药业股票老虎国际,双成药业行情,双成药业股票行情,双成药业股价,双成药业股市,双成药业股票价格,双成药业股票交易,双成药业股票购买,双成药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}